Literature DB >> 6781255

Gastrointestinal radiographic features of human graft-vs.-host disease.

J D Fisk, H M Shulman, R R Greening, G B McDonald, G E Sale, E D Thomas.   

Abstract

Following allogeneic bone marrow transplantation, graft-versus-host disease (GVHD) develops when the foreign donor lymphoid graft mounts an immunologic reaction against the skin, liver, and gastrointestinal tract of the host. The GVHD syndrome is characterized by skin rash, hepatocellular dysfunction, and secretory diarrhea with destruction of intestinal mucosa. The gastrointestinal radiographic manifestations of proven GVHD were studied in 16 allogeneic marrow recipients transplanted for aplasia (nine) or leukemia (seven). The radiographic findings revealed three distinct phases that correlated with the duration of active gastrointestinal GVHD: (1) Acute phase-seven examinations were performed 4-15 days after the onset of gastrointestinal GVHD, 19-44 days posttransplant. There were simultaneous and uniform changes in the stomach through the small bowel consisting of thickened or flattened mucosal folds, thickening of the bowel wall, rapid transit, and excess luminal fluid. (2) Subacute phase-17 examinations were performed 13-96 days after the onset of gastrointestinal GVHD (40-118 days posttransplant). Abnormalities similar to those of the acute phase were noted, often with a striking segmental distribution. (3) Resolution phase-three patients, who earlier had sequential examinations, were studied when GVHD was no longer clinically active, 43-46 days after the onset of gastrointestinal GVHD (52-94 days posttransplant). These examinations showed improvement, with no abnormalities or effacement of mucosal folds. Mural thickening was confined to the terminal ileum. Gastrointestinal GVHD resolved in the three survivors; it persisted until death in nine of 13. The pathogenic mechanisms and differential diagnosis of the radiographic abnormalities are discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6781255     DOI: 10.2214/ajr.136.2.329

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Graft-versus-host disease of the intestine.

Authors:  G J Cox; G B McDonald
Journal:  Springer Semin Immunopathol       Date:  1990

2.  How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.

Authors:  George B McDonald
Journal:  Blood       Date:  2016-01-04       Impact factor: 22.113

3.  Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

Authors:  Andrew R Rezvani; Barry E Storer; Rainer F Storb; Marco Mielcarek; David G Maloney; Brenda M Sandmaier; Paul J Martin; George B McDonald
Journal:  Biol Blood Marrow Transplant       Date:  2011-07-30       Impact factor: 5.742

4.  Vitamin B12 absorption after allogeneic bone marrow transplantation.

Authors:  D W Milligan; A Quick; D L Barnard
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

5.  Rectal inflammation as first manifestation of graft-vs-host disease: radiologic-pathologic findings.

Authors:  Vito Cantisani; Koenraad J Mortele; Salvatore G Viscomi; Jonathan Glickman; Stuart G Silverman; Pablo R Ros
Journal:  Eur Radiol       Date:  2003-01-17       Impact factor: 5.315

6.  Videofluoroscopy of the pharynx and esophagus in chronic graft-versus-host disease.

Authors:  W Schima; P Pokieser; C Forstinger; K Uranitsch; P Kalhs; E Schober; P Kier; D Tscholakoff
Journal:  Abdom Imaging       Date:  1994 May-Jun

7.  Radiographic features of small intestinal injury in human graft-versus-host disease.

Authors:  M Schimmelpenninck; F Zwaan
Journal:  Gastrointest Radiol       Date:  1982

8.  Prolonged Intestinal Mucosal Barium Coating due to Ischemic Necrosis.

Authors:  Vincent H S Low
Journal:  Case Rep Radiol       Date:  2011-09-19

Review 9.  Gastrointestinal complications following hematopoietic stem cell transplantation in children.

Authors:  Ji-Hye Lee; Gye-Yeon Lim; Soo Ah Im; Nak-Gyun Chung; Seung-Tae Hahn
Journal:  Korean J Radiol       Date:  2008 Sep-Oct       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.